X0203
3
2011-04-01
0
0001274644
TRANZYME INC
TZYM
0001515616
Thomas Helmut
C/O TRANZYME, INC.
4819 EMPEROR BOULEVARD, SUITE 400
DURHAM
NC
27703
0
1
0
0
Sr. VP, Research & Preclinical
Stock Option (right to buy)
3.78
2018-02-19
Common Stock
35714
D
Stock Option (right to buy)
3.78
2018-02-19
Common Stock
14285
D
Stock Option (right to buy)
3.78
2018-02-19
Common Stock
14893
D
Stock Option (right to buy)
3.78
2018-02-19
Common Stock
14893
D
25% of the shares vested and became exercisable on June 5, 2007, with the remainder vesting and becoming exercisable in equal quarterly installments for the following 12 quarters thereafter, so that the entire option is presently fully vested and exercisable.
25% of the shares vested and became exercisable on January 4, 2008, with the remainder vesting and becoming exercisable in equal quarterly installments for the following 12 quarters thereafter, so that the entire option is presently fully vested and exercisable.
25% of the shares vested and became exercisable on October 26, 2008, with the remainder vesting and becoming exercisable in equal quarterly installments for the following 12 quarters thereafter.
25% of the shares vested and became exercisable on February 1, 2009, with the remainder vesting and becoming exercisable in equal quarterly installments for the following 12 quarters thereafter.
Exhibit 24.1 Power of attorney
/s/ Richard I. Eisenstadt, attorney-in-fact
2011-04-01